Compugen (CGEN) Director Halevy Gilead Receives Awards

What Happened Halevy Gilead, a director of Compugen Ltd. (CGEN), was granted two awards on 2026-07-29: 7,500 restricted stock units (RSUs) and a 10,000-unit derivative award (an option-type grant). Both grants show an acquisition price of $0.00 (i.e., they were awarded as compensation). The combined grant totals 17,500 units; no cash changed hands in this transaction.

Key Details

• Transaction date and price: 2026-07-29; $0.00 per unit (award).
• Awards: 7,500 RSUs (Footnote F1) and 10,000 derivative units/options (Footnote F2).
• Vesting (both grants): 25% vests on October 1, 2027; the remainder vests in 12 equal quarterly installments thereafter, subject to continued service.
• Shares owned after transaction: Not disclosed in the information provided in this filing.
• Filing timeliness: Reported on 2026-07-30 for a 2026-07-29 transaction — appears to be filed timely.
• Transaction code: A = Award/Grant. No tax withholding or sale reported in this filing.

Context RSUs are rights to receive shares if and when they vest; the derivative award noted appears to be an option-style grant that vests over time and would require exercise terms later (strike price, if any, not disclosed here). These awards are typically compensation for board service and do not represent an open-market purchase or sale by the insider. Such grants are common and are compensation-related rather than immediate bullish bets by the insider.